se gb

Corrado Sablone joins Pergamum AB as Chief Financial Officer

Stockholm, May 30, 2011. Pergamum, a Swedish biotechnology company with focus on the development of new treatments for wounds and skin infections, today announced the hire of Corrado Sablone as Chief Financial Officer. Mr Sablone joins Pergamum from Coca Cola Enterprises Sverige AB, where he has been the Commercial Controlling Manager since 2006. Prior to Coca Cola, Corrado Sablone has served as business controller in several companies, including public international corporations such as Tetra Pak and Tradimus.

”Corrado brings outstanding financial and management expertise to our executive team as Pergamum further consolidates the group of companies and development programs. He will play a key role in our budgeting, management reporting, fund raising, and in supporting the growth of our financial organization,” said Jonas Ekblom, CEO of Pergamum.

“Pergamum is well-positioned to become a future leader in regards to innovation in the field of infectious diseases and wound healing” said Sablone. “I’m looking forward to working closely with Jonas and the rest of Pergamum’s excellent management team to aggressively pursue the company’s development and growth strategy.”

Mr Sablone holds a Masters Degree in business administration. He will assume his position with immediate effect.

For further information, please contact:

Jonas Ekblom, CEO       
Phone: +46 (8)524 89 100


About Pergamum
Pergamum is a biopharmaceutical company, with headquarters in Stockholm, that is specialized in the development of innovative drugs for the treatment of wounds and skin infections. The company is currently conducting a number of research and development programs, several being at clinical stage.


pdf.png  Corrado Sablone joins Pergamum AB as Chief Financial Officer